Using FXS patient derived iPSCs, we can not only study human-specific pathways dysregulated in FXS patient cells, but also understand how FMR1 gene silencing induced epigenetic changes affect other cellular processes beyond FMRP deficiency. The gene discussed is FMR1; the disease is fragile X syndrome.